Acura Pharmaceuticals, Inc. Share Price Nasdaq
Equities
US00509L7038
Biotechnology & Medical Research
Sales 2020 | 3.57M 283M | Sales 2021 | 1.56M 124M | Capitalization | 32.54M 2.58B |
---|---|---|---|---|---|
Net income 2020 | -1M -79.41M | Net income 2021 | - 0 | EV / Sales 2020 | 2.91 x |
Net Debt 2020 | 5.86M 465M | Net Debt 2021 | 135K 10.72M | EV / Sales 2021 | 20.9 x |
P/E ratio 2020 |
-5.25
x | P/E ratio 2021 |
-25
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 15.27% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Jones
CEO | Chief Executive Officer | 65 | 06/04/08 |
Peter Clemens
DFI | Director of Finance/CFO | 71 | 31/01/98 |
Bob Seiser
AUD | Comptroller/Controller/Auditor | 60 | 28/02/98 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Clemens
DFI | Director of Finance/CFO | 71 | 31/01/98 |
Bruce Wesson
BRD | Director/Board Member | 81 | 28/02/98 |
William Skelly
BRD | Director/Board Member | 73 | 30/04/96 |
1st Jan change | Capi. | |
---|---|---|
+5.33% | 111B | |
+12.11% | 106B | |
-12.56% | 22.24B | |
-3.70% | 21.25B | |
-6.03% | 18.97B | |
-35.21% | 18.52B | |
-10.86% | 16.81B | |
+5.10% | 13.94B | |
+37.57% | 12.54B |